How many institutions own FNCH stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own FNCH shares is 2, representing 0.47% of the company's common stock.

Who are the major shareholders selling Finch Therapeutics Group, Inc. stock?

SUSQUEHANNA INTERNATIONAL GROUP, LLP, in the last quarter, reduced its stake in FNCH by -100% restricting it's holding to 0 shares of worth nearly -. VANGUARD GROUP INC also lessened -100% of the FNCH shares from its portfolio, reducing its holding to 0 shares of worth -. UBS GROUP AG also shunned FNCH shares holding by -100% last quarter which brought its holding to 0 shares worth -.

Investors who are buying FNCH stock?

As per its latest 13F filing, N/A increased its stake in FNCH by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of FNCH to its portfolio, raising its holding to - shares of worth -. N/A also increased its FNCH shares holding by N/A which brought its holding to - shares worth -.

FNCH's major insiders: who are they?

The insider with the most stakes in FNCH is Crestovo Investor LLC , at the company. Additionally, FNCH stock is highly held by director Haft Nicholas and director FERRANTE DOMENIC J among others.

Did an insider recently sell FNCH stock?

Company executives, directors, and other insiders own 13.39% percent of Finch Therapeutics Group, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which FNCH insiders have sold stock, totaling 0 shares. Insiders that have sold shares include SMISEK JEFFERY A, BLAUSTEIN MARC, and VITTIGLIO JOSEPH.

Which insider recently purchased FNCH stock?

There have been 0 transaction(s) during the past 6-months in which Finch Therapeutics Group, Inc. insiders have bought stock, totalling 0 shares

How much of FNCH does insiders own?

Around 0 Finch Therapeutics Group, Inc. shares are held by insiders, which represents about 13.39% of FNCH stock.

Who is the insider with the largest stake?

FNCH , Crestovo Investor LLC holds the largest portfolio of the company's shares. FNCH shares owned by Crestovo total nearly 12.64 million.

Which institution holds the most shares in FNCH?

SUSQUEHANNA INTERNATIONAL GROUP, LLP is the largest institutional owner in FNCH which holds 0 shares worth - or 0% of the total FNCH shares outstanding followed by LAKE STREET ADVISORS GROUP, LLC with ownership of 21.21 thousand shares representing 1.32% of the FNCH ownership. VANGUARD GROUP INC is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.

Is Finch Therapeutics Group, Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the FNCH is concerned, it is a stock which is not optionable.

Is there a short position on FNCH's shares?

Number of FNCH shares short is 19.20K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding FNCH shares are there?

As of today, 1.61M shares of FNCH are outstanding.

Is there many float in FNCH stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, FNCH has 896.19K shares in float.

FNCH short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for FNCH is 0.19.

Finch Therapeutics Group (FNCH) insider trading activity: Get Latest News Today

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableNo

OptionableNo

Short Percent Of Outstanding Shares1.2

Short Percent Of Float2.76

Shares Outstanding1.61M

Shares Float896.19K

Shares Short19.20K

Short Ratio0.19

2.76%

Short % of Float

1.2%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

13.39% Percentage of Shares held by All Insiders

0.47% Percentage of Shares held by All Institutions

0.54% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 0.47% of FNCH shares are held by financial institutions. SUSQUEHANNA INTERNATIONAL GROUP, LLP is the top corporate investor, holding 0 shares valued at -. A 0% stake in Finch Therapeutics Group, Inc. is owned by the company. LAKE STREET ADVISORS GROUP, LLC owns 21.21K shares valued at $29.05K, which translates its holding of 1.32% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Jun 30, 2024	SUSQUEHANNA INTERNATIONAL GROUP, LLP	0%	0	-	-59.03K	-100.00%
Jun 30, 2024	LAKE STREET ADVISORS GROUP, LLC	1.32%	21.21K	29.05K	0	0
Jun 30, 2024	VANGUARD GROUP INC	0%	0	-	-36.25K	-100.00%
Jun 30, 2024	UBS GROUP AG	0%	0	-	-110	-100.00%
Jun 30, 2024	BLEICHROEDER LP	0%	0	-	-971	-100.00%
Jun 30, 2024	TOWER RESEARCH CAPITAL LLC (TRC)	0%	0	-	-4.16K	-100.00%
Jun 30, 2024	IKARIAN CAPITAL, LLC	0%	0	-	-6.89K	-100.00%
Jun 30, 2024	MORGAN STANLEY	0%	0	-	-156	-100.00%
Jun 30, 2024	WELLS FARGO & COMPANY/MN	0%	0	-	-7	-100.00%
Jun 30, 2024	BLACKROCK INC.	0%	0	-	-327	-100.00%
Jun 30, 2023	PROFICIO CAPITAL PARTNERS LLC	0%	0	-	-110.56K	-100.00%
Jun 30, 2023	WEALTHSOURCE PARTNERS, LLC	0%	0	-	-18K	-100.00%
Jun 30, 2023	ADVISOR GROUP HOLDINGS, INC.	0%	0	-	-249	-100.00%
Jun 30, 2023	STEWARD PARTNERS INVESTMENT ADVISORY, LLC	0%	0	-	-2.25K	-100.00%
Jun 30, 2023	LAKE STREET ADVISORS GROUP, LLC	0%	0	-	-739.14K	-100.00%
Jun 30, 2023	IKARIAN CAPITAL, LLC	0%	0	-	-237.55K	-100.00%
Jun 30, 2023	BLEICHROEDER LP	0%	0	-	-810.42K	-100.00%
Jun 30, 2023	AVENIR MANAGEMENT COMPANY, LLC	0.12%	55.45K	472.95K	-1.61M	-96.67%
Jun 30, 2023	BANK OF AMERICA CORP /DE/	0%	0	-	-56	-100.00%
Jun 30, 2023	WELLS FARGO & COMPANY/MN	0%	0	-	-159	-100.00%
Jun 30, 2023	STATE STREET CORP	0%	0	-	-24.48K	-100.00%
Jun 30, 2023	VANGUARD GROUP INC	0%	0	-	-1.02M	-100.00%
Jun 30, 2023	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0%	0	-	-18.78K	-100.00%
Jun 30, 2023	MORGAN STANLEY	0%	0	-	-710	-100.00%
Jun 30, 2023	GROUP ONE TRADING, L.P.	0%	0	-	-100	-100.00%
Jun 30, 2023	BALLENTINE PARTNERS, LLC	0%	0	-	-143.6K	-100.00%
Jun 30, 2023	BAUPOST GROUP LLC/MA	0%	0	-	-2.02M	-100.00%
Jun 30, 2023	GEODE CAPITAL MANAGEMENT, LLC	0%	0	-	-208.32K	-100.00%
Jun 30, 2023	MILLENNIUM MANAGEMENT LLC	0%	0	-	-48.67K	-100.00%
Jun 30, 2023	BLACKROCK INC.	0%	0	-	-73.84K	-100.00%
Jun 30, 2023	LAURION CAPITAL MANAGEMENT LP	0%	0	-	-58K	-100.00%
Jun 30, 2023	RENAISSANCE TECHNOLOGIES LLC	0%	0	-	-93K	-100.00%
Jun 30, 2023	NORTHERN TRUST CORP	0%	0	-	-25.26K	-100.00%
Jun 30, 2023	ANCORA ADVISORS, LLC	0%	0	-	-16K	-100.00%
Jun 30, 2023	SUSQUEHANNA INTERNATIONAL GROUP, LLP	0%	0	-	-1.77M	-100.00%
Jun 30, 2023	HIGHTOWER ADVISORS, LLC	0%	0	-	-13.83K	-100.00%
Jun 30, 2023	MSD PARTNERS, L.P.	0%	0	-	-153.4K	-100.00%
Jun 30, 2023	TOWER RESEARCH CAPITAL LLC (TRC)	0%	0	-	-8.91K	-100.00%
Jun 30, 2023	BOOTHBAY FUND MANAGEMENT, LLC	0%	0	-	-23.89K	-100.00%
Jun 30, 2023	UBS GROUP AG	0%	0	-	-63	-100.00%
Jun 30, 2023	SVB WEALTH LLC	0%	0	-	-253.05K	-100.00%

Insiders

Among the FNCH insiders holding of 13.39% of the stake in company, CRESTOVO INVESTOR LLC, , holds the largest shares of 12.64M. HAFT NICHOLAS, director, is the second largest FNCH insider with ownership of 4.06M shares. FERRANTE DOMENIC J, director, stands third with possession of 636.2K shares of that stake.

Insiders	Designation	Shares Held
CRESTOVO INVESTOR LLC		12.64M
HAFT NICHOLAS	director	4.06M
FERRANTE DOMENIC J	director	636.2K
VITTIGLIO JOSEPH	Chief Business & Legal Officer	31.36K
BLAUSTEIN MARC	Chief Operating Officer	28K
GRAF SUSAN E	director	5.01K
SMISEK JEFFERY A	director	0

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Mar 28, 2024	SMISEK JEFFERY A	SALE	2.57	6.64K	17.07K	0
Nov 22, 2023	SMISEK JEFFERY A	SALE	3.64	1.47K	5.35K	6.64K
Jun 09, 2023	GRAF SUSAN E	PURCHASE	0.27	5.01K	1.35K	5.01K
Feb 21, 2023	BLAUSTEIN MARC	SALE	0.38	4.62K	1.76K	28K
Oct 21, 2022	VITTIGLIO JOSEPH	SALE	1.39	3.64K	5.05K	31.36K
Oct 21, 2022	BLAUSTEIN MARC	SALE	1.39	3.64K	5.05K	32.61K
Dec 20, 2021	HAFT NICHOLAS	PURCHASE	10.18	63.85K	649.99K	4.06M
Mar 23, 2021	HAFT NICHOLAS	PURCHASE	17.00	882.35K	15M	882.35K
Mar 23, 2021	FERRANTE DOMENIC J	PURCHASE	17.00	102.94K	1.75M	636.2K
Mar 23, 2021	CRESTOVO INVESTOR LLC	PURCHASE	17.00	735.29K	12.5M	12.64M
Mar 23, 2021	SMISEK JEFFERY A	PURCHASE	17.00	88.24K	1.5M	1.69M

FNCH Stock Ownership Breakdown